Would you like to gain more information about the best small-cap biotech stocks under $10 in 2021? Then keep up reading and follow Insider Monkey’s latest article with us. Investors generally like healthcare and technology industries, since they prospects in long-term are above average. Actually, biotechnology is at the intersection of healthcare and technology, meaning a global market size of $727.1 billion by 2025, we knew from Insider Monkey.
So what are the best small-cap biotech stocks to buy under $10 in 2021? Let’s take a look at Insider Monkey’s list now. Assembly Biosciences Inc. stands on the fifth spot, with having 22 hedge funds whose total value is $195 million. Nowadays the company focuses on the treatment of hepatitis B (HBV), and novel oral biotherapeutic candidates for the treatment of disorders associated with the microbiome. In the end of 2020 Assembly announced that would concentrate on the advancement of novel core inhibitors for chronic HBV. In the third quarter, the company posted a GAAP EPS of -$0.09, above the Street’s estimates by $0.69. Revenue in the quarter jumped 718% to reach $34.61 million, beating the Street’s estimates by $28.17 million. Dynavax Technologies Corp. DVAX is on the fourth spot, with having 23 of hedge funds, with a total value of $58 million. The company is involved in producing cures for human’s body immune system stability. It works on producing Hepatitis B vaccine HEPLISAV-B, which is an adjuvant vaccine for hepatitis B. In January 2021, the company announced to make experiments with the first participant, who got the first dose for COVID-19. Its name is MVC-COV1901, and is a subunit vaccine with recombinant S-2P antigen adjuvanted with CpG 1018 supplied by Dynavax. On the second spot, we can see Kadmon Holdings LLC KDMN, with having 24 hedge funds with a total value of $304 million. Kadmon operates in development, discovery and commercialization of small molecules and biologics to address disease areas of significant unmet medical needs. In January 2021, Steve Cohen’s Point72 reported to own a 5.3% stake in the company, which actually means 9.05 million shares. For further information, please click and jump to best small-cap biotech stocks under $10 in 2021.